首页> 外文期刊>世界儿科杂志(英文版) >Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn''''s disease: a meta-analysis
【24h】

Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn''''s disease: a meta-analysis

机译:独家肠内营养与糖皮质激素治疗小儿克罗恩病的Meta分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Many studies have examined the effects of exclusive enteral nutrition (EEN) in children with Crohn''s disease (CD),but corticosteroids are considered a superior therapy and are frequently used in China.This meta-analysis aims to compare the efficacy of EEN with corticosteroids in treating pediatric CD.Methods A comprehensive retrieval from medical databases,including PubMed,EMBASE,MEDLINE,Web of Science,Wanfang data,VIP and CNKI,was performed using the search terms ''diet therapy'',''exclusive enteral nutrition'',''Crohn''s disease'',''inflammatory bowel diseases'',''child'' and ''pediatrics'' from January 1990 to April 2017.Results We included 18 studies from 1329 identified sources in this meta-analysis.EEN was as effective as corticosteroids in inducing remission rate of children suffering from CD (OR =1.35;95% CI 0.90,2.10;P =0.14).Nevertheless,patients who received EEN were more likely to achieve both endoscopic mucosal healing (OR =5.24;95% CI 2.06,13.37;P =0.0005)and histological mucosal healing (OR =4.78;95% CI 1.89,12.08;P=0.0009) than those who received corticosteroids;the Pediatric Crohn''s Disease Activity Index was lower [mean difference (MD)=-3.67;95% CI-4.91,-2.43] and weight gain was higher (MD=1.92;95% CI 0.02,3.83;P=0.05) in those patients who received EEN than in those who received corticosteroids.No difference was found in relapse rate (OR =0.57;95% CI 0.25,1.29;P=0.18),height for age or body mass index between the patients treated with EEN and corticosteroids at the 1-year end point.Conclusions This meta-analysis reveals that there is no significant difference between EEN and corticosteroids in the efficacy of inducing remission rate of CD in a pediatric population,but EEN is superior to corticosteroids in improving short-term mucosal inflammation and reducing the PCDAI index.
机译:背景许多研究已经检查了肠内营养(EEN)在克罗恩病(CD)儿童中的作用,但皮质类固醇被认为是一种较好的疗法,在中国经常使用。本荟萃分析旨在比较糖皮质激素的疗效。 EEN与皮质类固醇激素治疗小儿CD的方法使用搜索词“饮食疗法”,“专有”从医学数据库(包括PubMed,EMBASE,MEDLINE,Web of Science,Wanfang数据,VIP和CNKI)进行全面检索于1990年1月至2017年4月进行肠内营养'',``克罗恩氏病'',``炎症性肠病'',``儿童''和``儿科''研究。结果我们从1329个确定的来源中进行了18项研究在本荟萃分析中,EEN与皮质类固醇在诱导CD患儿缓解率方面的疗效相同(OR = 1.35; 95%CI 0.90,2.10; P = 0.14)。内镜黏膜愈合(OR = 5.24; 95%CI 2.06,13.37; P = 0.0005)和组织学上的黏膜愈合(OR = 4.78; 95%CI 1.89,12.08; P = 0.0009)比那些接受皮质类固醇激素治疗的小儿克罗恩病活动指数要低[平均差异(MD)=-3.67; 95%CI- [4.91,-2.43]并且接受EEN的患者的体重增加(MD = 1.92; 95%CI 0.02,3.83; P = 0.05)高于接受糖皮质激素的患者。复发率无差异(OR = 0.57) ; 95%CI 0.25,1.29; P = 0.18),在1年终点时EEN和皮质类固醇激素治疗的患者的年龄或体重指数的高度。结论这项荟萃分析显示EEN之间没有显着差异。和皮质类固醇在诱导小儿CD缓解率方面的功效,但EEN在改善短期粘膜炎症和降低PCDAI指数方面优于皮质类固醇。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号